Figure 2.
Platelet counts were measured in NOD/SCID mice that received different quantities of 211At. The circulating platelet counts were determined initially at weekly intervals and subsequently at monthly intervals. Mice in the control group did not receive any treatment (control). Mice in the other groups had received 400 μg of UPC10 mAb intravenously 30 minutes before they received 211At-7G7 at doses of 6, 12, 24, and 40 μCi (0.222, 0.444, 0.888, and 1.48 MBq).
